Reference health

Cardiac concerns associated with strontium ranelate

https://doi.org/10.1517/14740338.2014.939169
CiteStamped reference-health badge
14/14 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 14 checked references that resolve
resolves10.1056/NEJMoa022436
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
resolves10.1210/jc.2004-1774
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study
resolves10.1210/jc.2012-3048
Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men
resolves10.1002/art.23461
Effects of long‐term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five‐year, randomized, placebo‐controlled trial
resolves10.1007/s00198-011-1847-z
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
resolves10.1136/annrheumdis-2012-202231
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
resolves10.1007/s00296-012-2594-y
A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years
resolves10.1007/s00198-013-2582-4
Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case–control study in the CPRD
resolves10.1007/s00198-013-2469-4
Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate
resolves10.1136/annrheumdis-2014-205283
Use of strontium ranelate and risk of acute coronary syndrome: cohort study
resolves10.1007/s00198-013-2583-3
Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice
resolves10.1007/s00223-011-9499-8
Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
resolves10.1586/ecp.11.42
Adverse drug reactions to osteoporosis treatments
resolves10.1136/ard.2008.094516
Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1517/14740338.2014.939169"><img src="https://citestamp.com/citestamped/10.1517/14740338.2014.939169/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1517/14740338.2014.939169/badge.svg)](https://citestamp.com/citestamped/10.1517/14740338.2014.939169)